Literature DB >> 22167183

Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Kumar Somyajit1, Shreelakshmi Subramanya, Ganesh Nagaraju.   

Abstract

RAD51C, a RAD51 paralog, has been implicated in homologous recombination (HR), and germ line mutations in RAD51C are known to cause Fanconi anemia (FA)-like disorder and breast and ovarian cancers. The role of RAD51C in the FA pathway of DNA interstrand cross-link (ICL) repair and as a tumor suppressor is obscure. Here, we report that RAD51C deficiency leads to ICL sensitivity, chromatid-type errors, and G(2)/M accumulation, which are hallmarks of the FA phenotype. We find that RAD51C is dispensable for ICL unhooking and FANCD2 monoubiquitination but is essential for HR, confirming the downstream role of RAD51C in ICL repair. Furthermore, we demonstrate that RAD51C plays a vital role in the HR-mediated repair of DNA lesions associated with replication. Finally, we show that RAD51C participates in ICL and double strand break-induced DNA damage signaling and controls intra-S-phase checkpoint through CHK2 activation. Our analyses with pathological mutants of RAD51C that were identified in FA and breast and ovarian cancers reveal that RAD51C regulates HR and DNA damage signaling distinctly. Together, these results unravel the critical role of RAD51C in the FA pathway of ICL repair and as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167183      PMCID: PMC3270991          DOI: 10.1074/jbc.M111.311241

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Molecular analysis of sister chromatid recombination in mammalian cells.

Authors:  Nadine Puget; Melodie Knowlton; Ralph Scully
Journal:  DNA Repair (Amst)       Date:  2005-02-03

2.  Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells.

Authors:  M Takata; M S Sasaki; E Sonoda; C Morrison; M Hashimoto; H Utsumi; Y Yamaguchi-Iwai; A Shinohara; S Takeda
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

3.  Involvement of Brca2 in DNA repair.

Authors:  K J Patel; V P Yu; H Lee; A Corcoran; F C Thistlethwaite; M J Evans; W H Colledge; L S Friedman; B A Ponder; A R Venkitaraman
Journal:  Mol Cell       Date:  1998-02       Impact factor: 17.970

4.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

Review 5.  The Fanconi Anemia/BRCA pathway: new faces in the crowd.

Authors:  Richard D Kennedy; Alan D D'Andrea
Journal:  Genes Dev       Date:  2005-12-15       Impact factor: 11.361

6.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

7.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

8.  Association of BRCA1 with Rad51 in mitotic and meiotic cells.

Authors:  R Scully; J Chen; A Plug; Y Xiao; D Weaver; J Feunteun; T Ashley; D M Livingston
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

9.  DNA double-strand breaks measured in individual cells subjected to gel electrophoresis.

Authors:  P L Olive; D Wlodek; J P Banáth
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

10.  Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.

Authors:  J Chen; D P Silver; D Walpita; S B Cantor; A F Gazdar; G Tomlinson; F J Couch; B L Weber; T Ashley; D M Livingston; R Scully
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

View more
  32 in total

Review 1.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

Review 2.  Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia.

Authors:  Jie Li; Qishen Pang
Journal:  Antioxid Redox Signal       Date:  2014-03-11       Impact factor: 8.401

3.  Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids.

Authors:  Sarah J Hill; Brennan Decker; Emma A Roberts; Neil S Horowitz; Michael G Muto; Michael J Worley; Colleen M Feltmate; Marisa R Nucci; Elizabeth M Swisher; Huy Nguyen; Chunyu Yang; Ryuji Morizane; Bose S Kochupurakkal; Khanh T Do; Panagiotis A Konstantinopoulos; Joyce F Liu; Joseph V Bonventre; Ursula A Matulonis; Geoffrey I Shapiro; Ross S Berkowitz; Christopher P Crum; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2018-09-13       Impact factor: 39.397

4.  ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair.

Authors:  Kumar Somyajit; Shivakumar Basavaraju; Ralph Scully; Ganesh Nagaraju
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

5.  Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination.

Authors:  Aleksandra M Gorniewska; Katarzyna Kluzek; Lidia Gackowska; Izabela Kubiszewska; Malgorzata Z Zdzienicka; Aneta Bialkowska
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

6.  RAD51C/XRCC3 Facilitates Mitochondrial DNA Replication and Maintains Integrity of the Mitochondrial Genome.

Authors:  Anup Mishra; Sneha Saxena; Anjali Kaushal; Ganesh Nagaraju
Journal:  Mol Cell Biol       Date:  2018-01-16       Impact factor: 4.272

7.  Discovery of mutations in homologous recombination genes in African-American women with breast cancer.

Authors:  Yuan Chun Ding; Aaron W Adamson; Linda Steele; Adam M Bailis; Esther M John; Gail Tomlinson; Susan L Neuhausen
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

8.  TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer.

Authors:  Jeremy Chien; Hugues Sicotte; Jian-Bing Fan; Sean Humphray; Julie M Cunningham; Kimberly R Kalli; Ann L Oberg; Steven N Hart; Ying Li; Jaime I Davila; Saurabh Baheti; Chen Wang; Sabine Dietmann; Elizabeth J Atkinson; Yan W Asmann; Debra A Bell; Takayo Ota; Yaman Tarabishy; Rui Kuang; Marina Bibikova; R Keira Cheetham; Russell J Grocock; Elizabeth M Swisher; John Peden; David Bentley; Jean-Pierre A Kocher; Scott H Kaufmann; Lynn C Hartmann; Viji Shridhar; Ellen L Goode
Journal:  Nucleic Acids Res       Date:  2015-04-27       Impact factor: 16.971

Review 9.  PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.

Authors:  Jung-Young Park; Fan Zhang; Paul R Andreassen
Journal:  Biochim Biophys Acta       Date:  2014-07-03

10.  High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.

Authors:  Xiuli Chen; Dong Qian; Jingjing Cheng; Yong Guan; Bin Zhang; Xiaofeng Ding; Jing Zeng; Xi Chen; Puchun Er; Furong Zhang; Na Zhao; Xiaocen Chen; Lujun Zhao; Zhiyong Yuan; Qingsong Pang; Ping Wang
Journal:  Tumour Biol       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.